Shine Investment Advisory Services’s Monopar Therapeutics MNPR Stock Holding History

Shine Investment Advisory Services’s Portfolio MNPR Stock Details MNPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$0	Hold	2	–	–	﹤0.01%	748
2020 Q2	$0	Hold	2	–	–	﹤0.01%	755
2020 Q1	$0	Buy	+2	New	+$125	﹤0.01%	752

Other funds holding MNPR

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Shine Investment Advisory Services's MNPR Position: Q3 2020 in Review

Shine Investment Advisory Services held its Monopar Therapeutics (MNPR) position steady in Q3 2020 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #748.

Shine Investment Advisory Services first reported a position in MNPR in Q1 2020 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold MNPR as of Q3 2020.

Shine Investment Advisory Services held 2 shares of Monopar Therapeutics worth $0 as of Q3 2020.
Shine Investment Advisory Services left its Monopar Therapeutics share count unchanged in Q3 2020.
Monopar Therapeutics made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #748 holding.
Shine Investment Advisory Services first reported a position in Monopar Therapeutics in Q1 2020 and has held it in 3 quarters since.
6 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.